"Southampton Healthcare’s mission is to provide high-quality healthcare to our patients. We are committed to serving a diverse clientele with state of the art medical knowledge and compassionate care. We are here to partner with you in maintaining your health and well being."

During the past decade, Southampton Healthcare, Inc. conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 15 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southampton Healthcare, Inc." #1 sponsor was "Gilead Sciences" with 22 trials, followed by "Theratechnologies" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Glaxo Wellcome" with 1 trials sponsored and "GlaxoSmithKline" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southampton Healthcare, Inc." #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Southampton Healthcare, Inc." are "HIV-1 Infection" (11 trials), "HIV" (9 trials), "HIV Infections" (9 trials), "HIV-1-infection" (4 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Southampton Healthcare, Inc." in a lesser frequency.

Most popular intervention types in "Southampton Healthcare, Inc." are "Drug" (29 trials). Other intervention types were less common.

The name of intervention was led by "B/F/TAF" (4 trials), "E/C/F/TAF" (4 trials), "FTC/RPV/TDF" (4 trials), "F/TAF" (3 trials) and "F/TAF Placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Southampton Healthcare, Inc." are 29 trials for "All" genders.

Currently, there are NaN active trials in "Southampton Healthcare, Inc.". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Southampton Healthcare, Inc., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Southampton Healthcare, Inc., 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".